APO RESEARCH · REPORT
Human Organs-on-Chips
An Organ-On-Chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.
Product & engineering
Understand the product.
An Organ-On-Chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.
The primary focus of Organ-On-Chip technology is the re-creation of three key aspects of human physiology: the multicellular vascular or epithelial interfaces of organs (for example, blood vessel networks, lung and gut), which function as barriers in tissues; the tissue-level organization of parenchymal cells (for example, liver, heart, skeletal muscle and tumours), which are responsible for the key functional properties of an organ; and the systematic interaction of multiple organs (for example, drug absorption, distribution, metabolism and elimination involving the gut, circulation, liver and kidney).
In addition, the Blood-Brain Barrier is definitely more complex than a simple wall, controlling the passage of most solute that enters or leaves the brain. To address how this molecular sieve affects neural activity, some researchers have simulated the interaction between blood vessels and brain tissue on a series of interconnected "organ chips" when connected through this Blood-Brain Barrier (BBB) model. Endothelial cells, pericytes, astrocytes and neurons alter their gene expression. These technologies will achieve even more rapid development and application.
Selected research
Industry Growth & Trends
Global Human Organs-on-Chips Industry Growth and Trends Forecast to 2032
Market perspective
An Organ-On-Chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.
The primary focus of Organ-On-Chip technology is the re-creation of three key aspects of human physiology: the multicellular vascular or epithelial interfaces of organs (for example, blood vessel networks, lung and gut), which function as barriers in tissues; the tissue-level organization of parenchymal cells (for example, liver, heart, skeletal muscle and tumours), which are responsible for the key functional properties of an organ; and the systematic interaction of multiple organs (for example, drug absorption, distribution, metabolism and elimination involving the gut, circulation, liver and kidney).
In addition, the Blood-Brain Barrier is definitely more complex than a simple wall, controlling the passage of most solute that enters or leaves the brain. To address how this molecular sieve affects neural activity, some researchers have simulated the interaction between blood vessels and brain tissue on a series of interconnected "organ chips" when connected through this Blood-Brain Barrier (BBB) model. Endothelial cells, pericytes, astrocytes and neurons alter their gene expression. These technologies will achieve even more rapid development and application.
Read the full market overview
Global key players of Human Organs-on-Chips include Emulate, TissUse, Hesperos, CN Bio Innovations, Tara Biosystems and Draper Laboratory, etc. Top five players occupy for a share about 46%. North America is the largest market, with a share about 42%, followed by Asia-Pacific and Europe. In terms of product, Liver-on-a-chip is the largest segment, with a share over 28%. In terms of End User, Academic & Research Institutes is the largest market, with a share over 40%.
Report Scope
This report provides a structured, data-driven view of the global Human Organs-on-Chips market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Human Organs-on-Chips market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Human Organs-on-Chips market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Human Organs-on-Chips.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Human Organs-on-Chips market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Human Organs-on-Chips Market by Company
Emulate
TissUse
Hesperos
CN Bio Innovations
Tara Biosystems
Draper Laboratory
Mimetas
Nortis
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Else Kooi Laboratory
Human Organs-on-Chips Segment by Type
Brain-on-a-chip
Liver-on-a-chip
Kidney-on-a-chip
Lung-on-a-chip
Heart-on-a-chip
Intestine-on-a-chip
Vessel-on-a-chip
Other Organs
Human Organs-on-Chips Segment by End User
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Cosmetics Industry
Others
Human Organs-on-Chips Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Organs-on-Chips market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Organs-on-Chips and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Organs-on-Chips.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Organs-on-Chips manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Human Organs-on-Chips in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Brain-on-a-chip
- Liver-on-a-chip
- Kidney-on-a-chip
- Lung-on-a-chip
- Heart-on-a-chip
- Intestine-on-a-chip
- Vessel-on-a-chip
- Other Organs
Applications
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Cosmetics Industry
- Others
Companies covered
- Emulate
- TissUse
- Hesperos
- CN Bio Innovations
- Tara Biosystems
- Draper Laboratory
- Mimetas
- Nortis
- Micronit Microtechnologies B.V.
- Kirkstall
- Cherry Biotech SAS
- Else Kooi Laboratory
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Human Organs-on-Chips Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Human Organs-on-Chips Sales Estimates and Forecasts (2021-2032)
- 1.3 Human Organs-on-Chips Market by Type
- 1.3.1 Brain-on-a-chip
- 1.3.2 Liver-on-a-chip
- 1.3.3 Kidney-on-a-chip
- 1.3.4 Lung-on-a-chip
- 1.3.5 Heart-on-a-chip
- 1.3.6 Intestine-on-a-chip
- 1.3.7 Vessel-on-a-chip
- 1.3.8 Other Organs
- 1.4 Global Human Organs-on-Chips Market Size by Type
- 1.4.1 Global Human Organs-on-Chips Market Size Overview by Type (2021-2032)
- 1.4.2 Global Human Organs-on-Chips Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Human Organs-on-Chips Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Human Organs-on-Chips Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Human Organs-on-Chips Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Human Organs-on-Chips Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Human Organs-on-Chips Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Human Organs-on-Chips Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Human Organs-on-Chips Industry Trends
- 2.2 Human Organs-on-Chips Industry Drivers
- 2.3 Human Organs-on-Chips Industry Opportunities and Challenges
- 2.4 Human Organs-on-Chips Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Human Organs-on-Chips Revenue (2021-2026)
- 3.2 Global Top Players by Human Organs-on-Chips Sales (2021-2026)
- 3.3 Global Top Players by Human Organs-on-Chips Price (2021-2026)
- 3.4 Global Human Organs-on-Chips Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Human Organs-on-Chips Major Company Production Sites & Headquarters
- 3.6 Global Human Organs-on-Chips Company, Product Type & Application
- 3.7 Global Human Organs-on-Chips Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Human Organs-on-Chips Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Human Organs-on-Chips Players Market Share by Revenue in 2025
- 3.8.3 2025 Human Organs-on-Chips Tier 1, Tier 2, and Tier 3
4 Human Organs-on-Chips Regional Status and Outlook
- 4.1 Global Human Organs-on-Chips Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Human Organs-on-Chips Historic Market Size by Region
- 4.2.1 Global Human Organs-on-Chips Sales in Volume by Region (2021-2026)
- 4.2.2 Global Human Organs-on-Chips Sales in Value by Region (2021-2026)
- 4.2.3 Global Human Organs-on-Chips Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Human Organs-on-Chips Forecasted Market Size by Region
- 4.3.1 Global Human Organs-on-Chips Sales in Volume by Region (2027-2032)
- 4.3.2 Global Human Organs-on-Chips Sales in Value by Region (2027-2032)
- 4.3.3 Global Human Organs-on-Chips Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Human Organs-on-Chips by Application
- 5.1 Human Organs-on-Chips Market by End User
- 5.1.1 Pharmaceutical & Biotechnology Companies
- 5.1.2 Academic & Research Institutes
- 5.1.3 Cosmetics Industry
- 5.1.4 Others
- 5.2 Global Human Organs-on-Chips Market Size by End User
- 5.2.1 Global Human Organs-on-Chips Market Size Overview by Application (2021-2032)
- 5.2.2 Global Human Organs-on-Chips Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Human Organs-on-Chips Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by End User
- 5.3.1 North America Human Organs-on-Chips Sales Breakdown by End User (2021-2026)
- 5.3.2 Europe Human Organs-on-Chips Sales Breakdown by End User (2021-2026)
- 5.3.3 Asia-Pacific Human Organs-on-Chips Sales Breakdown by End User (2021-2026)
- 5.3.4 South America Human Organs-on-Chips Sales Breakdown by End User (2021-2026)
- 5.3.5 Middle East and Africa Human Organs-on-Chips Sales Breakdown by End User (2021-2026)
6 Company Profiles
- 6.1 Emulate
- 6.1.1 Emulate Company Information
- 6.1.2 Emulate Business Overview
- 6.1.3 Emulate Human Organs-on-Chips Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Emulate Human Organs-on-Chips Product Portfolio
- 6.1.5 Emulate Recent Developments
- 6.2 TissUse
- 6.2.1 TissUse Company Information
- 6.2.2 TissUse Business Overview
- 6.2.3 TissUse Human Organs-on-Chips Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 TissUse Human Organs-on-Chips Product Portfolio
- 6.2.5 TissUse Recent Developments
- 6.3 Hesperos
- 6.3.1 Hesperos Company Information
- 6.3.2 Hesperos Business Overview
- 6.3.3 Hesperos Human Organs-on-Chips Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Hesperos Human Organs-on-Chips Product Portfolio
- 6.3.5 Hesperos Recent Developments
- 6.4 CN Bio Innovations
- 6.4.1 CN Bio Innovations Company Information
- 6.4.2 CN Bio Innovations Business Overview
- 6.4.3 CN Bio Innovations Human Organs-on-Chips Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 CN Bio Innovations Human Organs-on-Chips Product Portfolio
- 6.4.5 CN Bio Innovations Recent Developments
- 6.5 Tara Biosystems
- 6.5.1 Tara Biosystems Company Information
- 6.5.2 Tara Biosystems Business Overview
- 6.5.3 Tara Biosystems Human Organs-on-Chips Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Tara Biosystems Human Organs-on-Chips Product Portfolio
- 6.5.5 Tara Biosystems Recent Developments
- 6.6 Draper Laboratory
- 6.6.1 Draper Laboratory Company Information
- 6.6.2 Draper Laboratory Business Overview
- 6.6.3 Draper Laboratory Human Organs-on-Chips Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Draper Laboratory Human Organs-on-Chips Product Portfolio
- 6.6.5 Draper Laboratory Recent Developments
- 6.7 Mimetas
- 6.7.1 Mimetas Company Information
- 6.7.2 Mimetas Business Overview
- 6.7.3 Mimetas Human Organs-on-Chips Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Mimetas Human Organs-on-Chips Product Portfolio
- 6.7.5 Mimetas Recent Developments
- 6.8 Nortis
- 6.8.1 Nortis Company Information
- 6.8.2 Nortis Business Overview
- 6.8.3 Nortis Human Organs-on-Chips Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Nortis Human Organs-on-Chips Product Portfolio
- 6.8.5 Nortis Recent Developments
- 6.9 Micronit Microtechnologies B.V.
- 6.9.1 Micronit Microtechnologies B.V. Company Information
- 6.9.2 Micronit Microtechnologies B.V. Business Overview
- 6.9.3 Micronit Microtechnologies B.V. Human Organs-on-Chips Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Micronit Microtechnologies B.V. Human Organs-on-Chips Product Portfolio
- 6.9.5 Micronit Microtechnologies B.V. Recent Developments
- 6.10 Kirkstall
- 6.10.1 Kirkstall Company Information
- 6.10.2 Kirkstall Business Overview
- 6.10.3 Kirkstall Human Organs-on-Chips Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Kirkstall Human Organs-on-Chips Product Portfolio
- 6.10.5 Kirkstall Recent Developments
- 6.11 Cherry Biotech SAS
- 6.11.1 Cherry Biotech SAS Company Information
- 6.11.2 Cherry Biotech SAS Business Overview
- 6.11.3 Cherry Biotech SAS Human Organs-on-Chips Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Cherry Biotech SAS Human Organs-on-Chips Product Portfolio
- 6.11.5 Cherry Biotech SAS Recent Developments
- 6.12 Else Kooi Laboratory
- 6.12.1 Else Kooi Laboratory Company Information
- 6.12.2 Else Kooi Laboratory Business Overview
- 6.12.3 Else Kooi Laboratory Human Organs-on-Chips Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Else Kooi Laboratory Human Organs-on-Chips Product Portfolio
- 6.12.5 Else Kooi Laboratory Recent Developments
7 North America by Country
- 7.1 North America Human Organs-on-Chips Sales by Country
- 7.1.1 North America Human Organs-on-Chips Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Human Organs-on-Chips Sales by Country (2021-2026)
- 7.1.3 North America Human Organs-on-Chips Sales Forecast by Country (2027-2032)
- 7.2 North America Human Organs-on-Chips Market Size by Country
- 7.2.1 North America Human Organs-on-Chips Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Human Organs-on-Chips Market Size by Country (2021-2026)
- 7.2.3 North America Human Organs-on-Chips Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Human Organs-on-Chips Sales by Country
- 8.1.1 Europe Human Organs-on-Chips Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Human Organs-on-Chips Sales by Country (2021-2026)
- 8.1.3 Europe Human Organs-on-Chips Sales Forecast by Country (2027-2032)
- 8.2 Europe Human Organs-on-Chips Market Size by Country
- 8.2.1 Europe Human Organs-on-Chips Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Human Organs-on-Chips Market Size by Country (2021-2026)
- 8.2.3 Europe Human Organs-on-Chips Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Human Organs-on-Chips Sales by Country
- 9.1.1 Asia-Pacific Human Organs-on-Chips Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Human Organs-on-Chips Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Human Organs-on-Chips Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Human Organs-on-Chips Market Size by Country
- 9.2.1 Asia-Pacific Human Organs-on-Chips Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Human Organs-on-Chips Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Human Organs-on-Chips Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Human Organs-on-Chips Sales by Country
- 10.1.1 South America Human Organs-on-Chips Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Human Organs-on-Chips Sales by Country (2021-2026)
- 10.1.3 South America Human Organs-on-Chips Sales Forecast by Country (2027-2032)
- 10.2 South America Human Organs-on-Chips Market Size by Country
- 10.2.1 South America Human Organs-on-Chips Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Human Organs-on-Chips Market Size by Country (2021-2026)
- 10.2.3 South America Human Organs-on-Chips Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Human Organs-on-Chips Sales by Country
- 11.1.1 Middle East and Africa Human Organs-on-Chips Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Human Organs-on-Chips Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Human Organs-on-Chips Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Human Organs-on-Chips Market Size by Country
- 11.2.1 Middle East and Africa Human Organs-on-Chips Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Human Organs-on-Chips Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Human Organs-on-Chips Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Human Organs-on-Chips Value Chain Analysis
- 12.1.1 Human Organs-on-Chips Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Human Organs-on-Chips Production Mode & Process
- 12.2 Human Organs-on-Chips Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Human Organs-on-Chips Distributors
- 12.2.3 Human Organs-on-Chips Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst